JP2024536798A5 - - Google Patents
Info
- Publication number
- JP2024536798A5 JP2024536798A5 JP2024517477A JP2024517477A JP2024536798A5 JP 2024536798 A5 JP2024536798 A5 JP 2024536798A5 JP 2024517477 A JP2024517477 A JP 2024517477A JP 2024517477 A JP2024517477 A JP 2024517477A JP 2024536798 A5 JP2024536798 A5 JP 2024536798A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- cancer
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111116842.X | 2021-09-23 | ||
| CN202111116842 | 2021-09-23 | ||
| PCT/CN2022/120481 WO2023046003A1 (zh) | 2021-09-23 | 2022-09-22 | 抗体药物偶联物及其制备方法和医药用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536798A JP2024536798A (ja) | 2024-10-08 |
| JP2024536798A5 true JP2024536798A5 (https=) | 2025-10-09 |
Family
ID=85720088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517477A Pending JP2024536798A (ja) | 2021-09-23 | 2022-09-22 | 抗体薬物コンジュゲート並びにその製造方法及び医薬用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240390509A1 (https=) |
| EP (1) | EP4406974A1 (https=) |
| JP (1) | JP2024536798A (https=) |
| KR (1) | KR20240058146A (https=) |
| CN (1) | CN118139891A (https=) |
| AU (1) | AU2022350725A1 (https=) |
| CA (1) | CA3232425A1 (https=) |
| TW (1) | TW202327663A (https=) |
| WO (1) | WO2023046003A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023083381A1 (zh) | 2021-11-15 | 2023-05-19 | 成都百利多特生物药业有限责任公司 | 双特异性抗体-喜树碱类药物偶联物及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0856054B1 (en) | 1995-10-19 | 2004-04-28 | Bristol-Myers Squibb Company | Monoclonal antibody br110 and uses thereof |
| US6653104B2 (en) | 1996-10-17 | 2003-11-25 | Immunomedics, Inc. | Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells |
| US7420040B2 (en) | 2006-02-24 | 2008-09-02 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| TWI495644B (zh) * | 2011-11-11 | 2015-08-11 | Rinat Neuroscience Corp | 營養層細胞表面抗原（Ｔｒｏｐ－２）之專一性抗體類及彼等之用途 |
| US9427464B2 (en) | 2011-11-22 | 2016-08-30 | Chiome Bioscience Inc. | Anti-human TROP-2 antibody having an antitumor activity in vivo |
| CN102827282B (zh) | 2012-09-04 | 2015-02-11 | 林红 | 人源抗Trop-2基因工程抗体IgG及其应用 |
| CN107446050A (zh) * | 2017-08-11 | 2017-12-08 | 百奥泰生物科技(广州)有限公司 | Trop2阳性疾病治疗的化合物及方法 |
| CN110903395A (zh) * | 2018-09-14 | 2020-03-24 | 四川科伦博泰生物医药股份有限公司 | 抗体、偶联物及其制备方法和用途 |
| JP2022505921A (ja) * | 2018-10-26 | 2022-01-14 | カファ セラピューティクス リミテッド | Ｃｌｌ１を標的とする抗体およびその応用 |
| CN112243443B (zh) | 2019-05-10 | 2023-03-17 | 江苏豪森药业集团有限公司 | 抗trop-2抗体、其抗原结合片段及其医药用途 |
| CN112168978B (zh) * | 2019-07-03 | 2022-01-11 | 北京大学 | 一种抗体偶联药物及其药物组合物与应用 |
-
2022
- 2022-09-22 CA CA3232425A patent/CA3232425A1/en active Pending
- 2022-09-22 KR KR1020247011071A patent/KR20240058146A/ko active Pending
- 2022-09-22 WO PCT/CN2022/120481 patent/WO2023046003A1/zh not_active Ceased
- 2022-09-22 US US18/694,370 patent/US20240390509A1/en active Pending
- 2022-09-22 EP EP22872048.8A patent/EP4406974A1/en active Pending
- 2022-09-22 CN CN202280062893.5A patent/CN118139891A/zh active Pending
- 2022-09-22 AU AU2022350725A patent/AU2022350725A1/en active Pending
- 2022-09-22 JP JP2024517477A patent/JP2024536798A/ja active Pending
- 2022-09-23 TW TW111136213A patent/TW202327663A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2985352T3 (es) | Anticuerpos para radionúclidos quelados | |
| TWI891749B (zh) | 抗體-藥物偶聯物及其醫藥用途 | |
| JP2023510905A5 (https=) | ||
| JP2022511351A5 (https=) | ||
| JP2019069983A (ja) | 新規抗体コンジュゲートおよびその使用 | |
| JP2020501531A5 (https=) | ||
| EP4523704A1 (en) | Camptothecin derivative and ligand-drug conjugate | |
| JP2013529059A5 (https=) | ||
| JP2023505708A5 (https=) | ||
| RU2014113304A (ru) | Анти-cd40-антитела, применение и методы | |
| JP2008526234A5 (https=) | ||
| RU2017112884A (ru) | Иммуноконъюгаты, содержащие антитела против her2 и пирролбензодиазепины | |
| WO2019050780A1 (en) | COMPOUNDS FOR REDUCING THE VISCOSITY OF BIOLOGICAL FORMULATIONS | |
| JP2023519261A5 (https=) | ||
| JP2023037000A (ja) | 抗ｃｄ４０抗体及びその使用 | |
| JP2024523422A (ja) | 抗腫瘍化合物およびその応用 | |
| JP2025539841A5 (https=) | ||
| CN115998900A (zh) | 抗trop-2抗体药物偶联物及其医药用途 | |
| TWI763956B (zh) | 治療癌症的抗前胃泌激素抗體與免疫療法之組合療法 | |
| JP2024536798A5 (https=) | ||
| JP2016540826A5 (https=) | ||
| JP2023536086A5 (https=) | ||
| AU2022350725A1 (en) | Antibody-drug conjugate, preparation method therefor, and pharmaceutical use thereof | |
| RU2021135114A (ru) | Конъюгат антитела к b7-h4 и лекарственного средства и его медицинское применение | |
| RU2024107004A (ru) | Анти-hla-g антитела |